Preclinical common data elements: a practical guide for use in epilepsy research.

Area of Science:

• Neuroscience
• Epilepsy Research
• Translational Medicine

Background:

• Despite progress in understanding epilepsy pathophysiology and identifying therapeutic targets, challenges remain in treating pharmacoresistant epilepsy and developing disease-modifying therapies.
• Variability in data capture, endpoint assessment, and experimental protocols across preclinical epilepsy research laboratories hinders consensus and the translation of findings.
• The need for reproducible and harmonized preclinical research is critical for advancing epilepsy treatment development.

Purpose of the Study:

• To provide guidance on implementing common data elements (CDEs) and case report forms (CRFs) for preclinical epilepsy research.
• To address the logistical challenges faced by investigators, particularly new researchers, in adopting standardized data collection approaches.
• To promote harmonization of standard operating procedures across laboratories and facilitate collaboration in large-scale, multi-site epilepsy research.

Main Methods:

• The commentary reviews the importance of CDEs and CRFs in enhancing the reproducibility of preclinical epilepsy research.
• It offers practical guidance, key considerations, and examples for establishing and utilizing CDEs and best practices for data collection.
• The focus is on practical implementation for both new and established research laboratories.

Main Results:

• Standardizing data collection through CDEs and CRFs can significantly improve the reproducibility of preclinical epilepsy research.
• Implementation of these standardized approaches aids in achieving consensus on critical research findings.
• Guidance provided facilitates the adoption of CDEs, supporting the development of robust research programs and collaborative efforts.

Conclusions:

• Adopting common data elements (CDEs) and standardized case report forms (CRFs) is essential for improving the reproducibility and reliability of preclinical epilepsy research.
• This harmonization facilitates consensus-building and accelerates the development of novel epilepsy treatments.
• The guidance presented empowers investigators to implement standardized data collection, fostering collaboration and advancing the field of epilepsy research.